MedPath

Early Warning Scores in Pregnant Woman

Not Applicable
Completed
Conditions
Pregnancy Complications
Registration Number
NCT06488690
Lead Sponsor
Suleyman Demirel University
Brief Summary

Our study aims to evaluate the use of early warning scores as a screening tool to predict obstetric mortality and morbidity in pregnant women who will undergo cesarean section.

Detailed Description

Our study aims to evaluate the use of early warning scores as a screening tool to predict obstetric mortality and morbidity in pregnant women who will undergo cesarean section.

This prospective study included 304 patients undergoing cesarean section at Suleyman Demirel University between April 2022 and April 2023. Physiological parameters were assessed in all 304 pregnant women before the operation. Maternal early warning scores, including modified early obstetric warning score (MEOWS), maternal early warning score (MEWC), and maternal early warning triggers (MEWT), were calculated for each patient. Patients triggering the system were classified as Group 1 (risky patients), while those not triggering the system were classified as Group 2 (risk-free patients).

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
304
Inclusion Criteria
  • All patients who are pregnant and undergo cesarean section
Exclusion Criteria
  • None

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Primary Outcome Measures
NameTimeMethod
MEWT scoreOne year

For MEWT, the presence of a "trigger" defined as either a single severely abnormal parameter (falling in the "red" zone) or two mildly abnormal parameters (falling in the "yellow" zone) was categorized as the risky group, with the absence or mildness of the trigger considered as the risk-free group.

MEOWS, MEWC and MEWT scoresOne year

The presence of a "trigger" for MEOWS in all systems, defined as either a single severely abnormal parameter (falling in the "red" zone) or two slightly abnormal parameters (falling in the "yellow" zone), was categorized as the risky group. Absence or mildness of the trigger was considered as the risk-free group.

MEWC scoreOne year

In the case of MEWC, the presence of only one abnormal parameter designated the risk group, while the absence of a trigger indicated the risk-free group.

Secondary Outcome Measures
NameTimeMethod
Aldrete scoreOne year

The Modified Aldrete Recovery Score System was computed for mothers to assess postoperative recovery.

APGAR scoreOne year

APGAR scores at 1st and 5th minutes were calculated for postnatal babies.

Glasgow Coma ScaleOne year

The Glasgow Coma Scale (GCS) was used to evaluate the consciousness of pregnant women.

Trial Locations

Locations (1)

Suleyman Demirel University

🇹🇷

Isparta, Merkez, Turkey

Suleyman Demirel University
🇹🇷Isparta, Merkez, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.